Thomas Meier
Chief Executive Officer en BACHEM HOLDING AG .
Fortuna: 1 M $ al 31/03/2024
Cargos activos de Thomas Meier
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
BACHEM HOLDING AG | Chief Executive Officer | 01/01/2020 | - |
Chief Operating Officer | 01/01/2019 | 01/01/2020 | |
Bachem (U.K.) Ltd.
Bachem (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Bachem Holding AG, Bachem (U.K.) Ltd. is a leading, British innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The private company is based in St. Helens, UK. The company's dedicated and experienced project leaders ensure the development and manufacturing of products through close collaboration with the project team. Whatever the needs for non-GMP products, Bachem can prepare compounds according to specifications in any scale. Founded in 1986, the company provides solutions for today and innovation for tomorrow. | Director/Board Member | 11/12/2018 | - |
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Chairman | 01/01/1993 | - |
Historial de carrera de Thomas Meier
Formación de Thomas Meier.
Zhaw School of Engineering | Undergraduate Degree |
Estadísticas
Internacional
Suiza | 4 |
Reino Unido | 2 |
Operativa
Chief Executive Officer | 1 |
Chief Operating Officer | 1 |
Director/Board Member | 1 |
Sectorial
Health Technology | 4 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
BACHEM HOLDING AG | Health Technology |
Empresas privadas | 2 |
---|---|
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Health Technology |
Bachem (U.K.) Ltd.
Bachem (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Bachem Holding AG, Bachem (U.K.) Ltd. is a leading, British innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The private company is based in St. Helens, UK. The company's dedicated and experienced project leaders ensure the development and manufacturing of products through close collaboration with the project team. Whatever the needs for non-GMP products, Bachem can prepare compounds according to specifications in any scale. Founded in 1986, the company provides solutions for today and innovation for tomorrow. | Health Technology |
- Bolsa de valores
- Insiders
- Thomas Meier
- Experiencia